Kromek Share Discussion Threads

[estienne] 21/3/2024 09:48

And Simon Thompson

[1luckylee] 20/3/2024 20:19

Something needs to happen to remove Arnab Basu before there is nothing left to save.

[croasdalelfc] 09/3/2024 07:49

Polymer had 57m when the new loan was announced - now they have 84m which is the rest of the shares from CLNPolymer now has a material interest with 84m with 13% and are owed £5.5m by KMK

[croasdalelfc] 09/3/2024 07:39

Herald have gained 15m shares since Oct. All likely from CLN conversion

[quepassa] 07/3/2024 08:04

they already had 4.9% if memory serves correctly.


just guessing but....

???were they one of the mystery holders of the convertible loan notes who took shares instead of cash repayment????

??? i guess Polymer N2 may or may not have been a similar situation judging by the RNS a couple of days ago??

both RNS's coincidentally and rapidly following the GM convened to increase shares in issue.


all imo. dyor.
qp

[18bt] 07/3/2024 07:34

Where did they suddenly get stake from?

[b00mb0y] 15/2/2024 20:42

Wonder where 33mick is. Not heard from him for a while. Hmmm

[quepassa] 15/2/2024 20:27

The headline title in The Times article/interview of 26/12/23 may or may not prove to be prophetic.

all imo. dyor.
qp

[ark87] 15/2/2024 19:12

Pump over now run for the hills. That could be their last pump before disaster hits.

[andrew97] 12/2/2024 11:45

I have kept the same percentage so have topped up over the last year, fools and their money! I am actually expecting a fall later today as there are lots of sells and no buys or there is a big buy being worked through. I am still of the opinion the technology will become recognised and drive the price later in the year. I am somewhat encouraged by the conversion as it saves cash (which is presumably short anyway) and it reinforces my view that those who held the bonds see value (otherwise they would force a cash payment). I still feel an obstacle would be winning a big order and not having the working cap to deliver, maybe thats the thought of buyers doing due diligence. Still underwater but not as deep as when they were 4p.

[croasdalelfc] 12/2/2024 09:51

How long will the £3.7m last ? That was last Oct 31st. Probably more like £2.5m now Maybe until end April or May as they need to keep £1m or so for working capital - then another raise ?

[croasdalelfc] 12/2/2024 08:26

50% dilution in 9 months - 432m shares to 641m

[quepassa] 12/2/2024 07:47

Started the year with c. 600 million shares in issue.

Now 641 million shares intended to be in issue (post Admission/GM).

Significant shareholder dilution.

They've been issuing shares at such a fast rate of knots - that they don't even have sufficient headroom left under existing company powers to issue today's new 16.5 million shares without calling a GM to increase their authorities.


The question is why they didn't pay back any of the Convertible Loans in cash......


And the amount of recent shareholder dilution is truly staggering.




ALL IMO. DYOR.
QP

[riskybisky] 06/2/2024 04:08

Proactive interview
Kromek Group's positive trajectory
Last updated: 09:45 03 Feb 2024 GMT First Published: 09:37 03 Feb 2024 GMT
Written by: Ian Lyall

Chatting with Proactive's Stephen Gunnion, Kromek Group PLC (AIM:KMK) CEO Arnab Basu shared an optimistic outlook on the company's first-half financial and operational achievements.

With a spotlight on increased revenue, improved gross margins and a notably reduced loss, Basu's insights offer a glimpse into the strategic directions propelling Kromek towards sustained growth.

Stephen Gunnion (SG): Arnab, Kromek's interim results indicate a strong first half with notable financial improvements. Can you elaborate on these achievements?

Arnab Basu (AB): Absolutely, Stephen. We've experienced a period of positive momentum, underpinned by a significant improvement in our EBITDA position and reduced pre-tax losses.

This success stems from our unwavering focus on profitability, achieved through diligent cost control and enhancing our business margins. Our growth has been particularly robust in the advanced imaging and CBRN segments, reflecting our alignment with market demands and our strategic initiatives in these areas.

SG: Could you dive deeper into the growth drivers within your main business segments?

AB: Certainly. Our advanced imaging segment, especially in SPECT and CT modalities, has seen increasing adoption of our CZT material, revolutionizing digital spectrums and enhancing diagnostic capabilities. This trend is underscored by new product launches and significant partnerships, such as our collaboration with a CT Original Equipment Manufacturer (OEM) and Spectrum Dynamics' launch of a new product.

On the CBRN front, global security concerns have spiked demand for our handheld radiation detection tools. Our contract wins and robust pipelines in this segment, alongside partnerships for biosecurity projects with the US and UK governments, mark our strategic advancements and readiness to meet evolving market needs.

SG: With the momentum built in the first half, how do you anticipate this will impact Kromek's performance moving into the full year 2024?

AB: The trajectory we've set in the first half is expected to continue, with the second half traditionally being stronger for us. We're on track to achieve record revenues, a testament to our growth strategy's effectiveness.

Our focus remains on cost control and margin improvement, positioning us to report not only significant revenue growth but also a positive EBITDA for the year. This marks a pivotal step towards our long-term profitability and underscores our commitment to delivering value.

[b00mb0y] 05/2/2024 17:38

Why is no one talking about this company.Looks like it has legs to double from here.

My view is; it’s been 10 years of misery for us long term investors. Take a look at the share price trend graph. It’s now showing that little repeated spike. The trend! Look what happens after that.
Saying that, there are many talking about this company and how good they and their products are but that’s it. Sp drops the more we hear.

I’m just hoping, as usual, that this time it continues to go up. Having said that, I’m a long, long way off my breakeven. Fingers crossed but not holding my breath.

[orlando42] 05/2/2024 16:20

Just a small point. I notice that neither the Board nor the Management Team contain any women. Particularly in this day and age this seems to me to be not a good sign. Boys Club mentality?

[brynos] 05/2/2024 11:30

KROMEK GROUP PLC
Released 10:17:36 05 February 2024

RNS Number : 0345C
Kromek Group PLC
05 February 2024

5 February 2024

Kromek Group plc

("Kromek" or the "Company" or the "Group")



Conversion of £1.5m of Convertible Loan Notes



Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, announces that two holders of the convertible loan notes ("Loan Notes") issued in August 2022 have elected to convert them into new ordinary shares of 1 penny each in the Company ("Ordinary Shares") at conversion prices of 6.3 pence and 7.1 pence, per Ordinary Share.



Including accrued interest, the Loan Note holders are converting £1,509,211 of debt into 23,639,520 new Ordinary Shares and accordingly these new Ordinary Shares have been issued and allotted by the board.



The issue prices of 6.3 and 7.1 pence per new Ordinary Share represent the closing price of the Company's Ordinary Shares on AIM on 31 January 2024 and 2 February 2024, respectively, being the repayment date of the convertible loan note facilities.



Application has been made for the 23,639,520 Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on or around 8.00 a.m. on 9 February 2024 ("Admission").



The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following Admission, the Company's issued share capital will consist of 623,886,340 Ordinary Shares, none of which are held in treasury. Accordingly, the figure of 623,886,340 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

[mcpaulas] 05/2/2024 10:47

Why is no one talking about this company.Looks like it has legs to double from here.

[aqc888] 03/2/2024 18:13

As for Simon Thompson’s tips on Kromek… it’s the same story in nearly every of the last 10 articles about Kromek… revenue is increasing and they’re about to turn a profit… it never happens… then everyone gets diluted and everything is repeated again. It’s bizarre. Quepassa, I can vote up a message but not vote down a message as a non paying participant here

[aqc888] 03/2/2024 18:09

Could anyone update me on what’s happened to the biological pathogen detectors? They were billed as Kromeks bright future not long ago, now they seem to be some strange dream I had. Not mentioned at all…?

[quepassa] 03/2/2024 07:14

7069

Eight upvotes.

That's telling you something.


all imo. dyor.
qp

[b00mb0y] 02/2/2024 21:37

@ 33mick.
It’s only been ten years of down trend gloom so any long term holders have got every right to moan/complain. Are we going to see a breakout here? I hope so. I want my money back.
Have you bought in yet, 33mick? Go on….. reveal?

[quepassa] 02/2/2024 10:42

if it's all so wonderful, just why are the Directors not buying any shares?

7067 refers

[33mick] 02/2/2024 10:01

It's probably also the mostly positive company webcast the other day, medical CZT tech module timeline use was referred to as being in decades, with other multi year supply contacts excepted soon + new to me some £100 mil of live tenders out for multi handheld D3/D5 radiation detectors, which they expect to get a healthy % of, so not as gloomy as the doomsters on here moan on about... endlessly..

[estienne] 01/2/2024 12:50

ST claims that they have won £8M in contracts in the last 6 months